Can a greater trochanteric bursa injection be performed after total hip arthroplasty in an older adult with trochanteric bursitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Greater Trochanteric Bursa Injections After Total Hip Arthroplasty

Yes, greater trochanteric bursa injections can be safely performed after total hip arthroplasty and are an effective first-line treatment for post-operative trochanteric bursitis, with 74-80% of patients responding to conservative management including corticosteroid injections. 1, 2

Clinical Context and Safety

Greater trochanteric pain syndrome (trochanteric bursitis) is a common complication following total hip arthroplasty, occurring in approximately 4.6-6.1% of patients regardless of surgical approach. 1, 2 The key safety consideration is distinguishing this extra-articular soft tissue pathology from intra-articular prosthetic joint infection (PJI), as the guidelines emphasize caution with injections in the presence of prosthetic joints. 3

The critical distinction is that trochanteric bursa injections are extra-articular (outside the joint capsule), whereas the infection risk concerns in the guidelines primarily relate to intra-articular injections near prosthetic implants. 4, 3

Diagnostic Approach

Clinical Diagnosis

  • Physical examination with palpation over the greater trochanter is the primary diagnostic method used by most surgeons. 5
  • Pain localized to the lateral hip that does not involve the hip joint itself distinguishes this from intra-articular pathology. 5

Imaging Guidance

  • Ultrasound is the preferred imaging modality for both diagnosis and injection guidance, as it can evaluate superficial structures like the abductor tendons and trochanteric bursa without ionizing radiation. 4
  • Fluoroscopic guidance improves accuracy significantly—blind injections achieve correct bursal placement only 45% of the time on first attempt, compared to higher success rates with imaging. 6
  • MRI can identify associated pathology including abductor tendinosis, tears, or calcific tendonitis when diagnosis is uncertain. 4

Treatment Algorithm

First-Line Management

  1. Oral anti-inflammatory medications (used by 57.1% of surgeons as initial therapy). 5
  2. Structured physiotherapy (52.4% of surgeons). 5
  3. Image-guided corticosteroid injection into the greater trochanteric bursa (45.2% of surgeons, 74-80% effective). 1, 2, 5

Injection Technique Specifics

  • Target the greater trochanteric bursa specifically rather than the subgluteus medius bursa—injections into the greater trochanteric bursa provide significantly better pain reduction (median reduction of 3 points vs 0 points on visual analog scale, p<0.01). 7
  • Use ultrasound or fluoroscopic guidance to ensure accurate needle placement, as blind injections frequently miss the target. 6, 8
  • Inject a 3-mL corticosteroid solution under direct imaging guidance. 7

Expected Outcomes

  • 80% of patients achieve symptom resolution with conservative management including injections. 2
  • 45% of patients require multiple injections for complete resolution. 2
  • Younger patients and those with significant leg-length discrepancy may be more likely to fail nonoperative treatment. 2

Risk Factors for Post-THA Trochanteric Bursitis

History of preoperative corticosteroid injection is the strongest predictor of requiring postoperative injections (adjusted odds ratio 3.772, p<0.001). 9

Additional risk factors include:

  • Female sex (stronger risk factor than surgical approach). 9
  • Posterior surgical approach (11.5% incidence vs 7.3% with anterior approach, adjusted odds ratio 1.242, p=0.001). 9
  • History of smoking. 1
  • Lumbar spinal stenosis. 1

Critical Pitfalls to Avoid

  • Do not confuse extra-articular trochanteric bursa injections with intra-articular hip joint injections—the infection risk profile differs substantially, and trochanteric injections do not violate the prosthetic joint space. 4, 3
  • Avoid blind injections without imaging guidance, as accuracy is poor (only 45% correct placement on first attempt). 6
  • Do not inject the subgluteus medius bursa when targeting trochanteric bursitis—this location is significantly less effective. 7
  • Consider that up to one-third of patients may fail initial conservative therapy and require multiple treatment modalities. 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.